Skip to main content
SpringerLink
Log in

CD4+ cell count criteria could control costs in US ADAPs

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Linas BP, Zheng H, Losina E, Rockwell A, Walensky RP, Cranston K, Freedberg KA.Optimizing resource allocation in United States AIDS Drug Assistance programs. Clinical Infectious Diseases 43: 1357-1364, No. 10, 15 Nov 2006

  2. Saag MS.Which policy to ADAP-T: waiting lists or waiting lines? Clinical Infectious Diseases 43: 1365-1367, No. 10, 15 Nov 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

CD4+ cell count criteria could control costs in US ADAPs. Pharmacoecon. Outcomes News 518, 8 (2006). https://doi.org/10.2165/00151234-200605180-00024

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605180-00024

Keywords

Search

Navigation